Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 19,445 | 11,647 | 2,706 | 2,761 | 1,371 |
| Accounts receivable | -12,455 | -10,606 | 1,927 | -15,415 | -650 |
| Accounts payable and accrued liabilities | 860 | 13,394 | N/A | N/A | N/A |
| Other Working Capital | 5,448 | -5,608 | -6,817 | -21,633 | 4,520 |
| Other Operating Activity | 31,090 | -42,288 | -77,345 | -123,405 | -75,099 |
| Operating Cash Flow | $44,388 | $-33,461 | $-79,529 | $-157,692 | $-69,858 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -281 | -718 | -292 | -297 | -5,584 |
| Purchase Of Investment | -545,832 | -523,500 | -523,993 | -438,958 | -202,951 |
| Sale Of Investment | 585,418 | 529,376 | 464,316 | 354,427 | 52,108 |
| Purchase Sale Intangibles | N/A | 0 | 0 | -1,198 | -1,675 |
| Other Investing Activity | -43 | -11,864 | -663 | -17,844 | -84 |
| Investing Cash Flow | $39,262 | $-6,706 | $-60,632 | $-103,870 | $-158,186 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11,989 | -10,025 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 0 | 0 | 196,740 | 187,732 |
| Common Stock Repurchased | -40,239 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 3,136 | 4,895 | 2,433 | 24,372 | 6,643 |
| Financing Cash Flow | $-49,092 | $-5,130 | $2,433 | $221,112 | $194,375 |
| Beginning Cash Position | 48,875 | 94,172 | 231,900 | 272,350 | 306,019 |
| End Cash Position | 83,433 | 48,875 | 94,172 | 231,900 | 272,350 |
| Net Cash Flow | $34,558 | $-45,297 | $-137,728 | $-40,450 | $-33,669 |
| Free Cash Flow | |||||
| Operating Cash Flow | 44,388 | -33,461 | -79,529 | -157,692 | -69,858 |
| Capital Expenditure | -281 | -718 | -292 | -1,501 | -7,343 |
| Free Cash Flow | 44,107 | -34,179 | -79,821 | -159,193 | -77,201 |